Related references
Note: Only part of the references are listed.Photodynamic therapy: illuminating the road from cell death towards anti-tumour immunity
Abhishek D. Garg et al.
APOPTOSIS (2010)
Atg7 deficiency increases resistance of MCF-7 human breast cancer cells to photodynamic therapy
Liang-yan Xue et al.
AUTOPHAGY (2010)
Vaccine Prevention of Cancer: Can Endogenous Antigens Be Targeted?
Louis M. Weiner et al.
CANCER PREVENTION RESEARCH (2010)
Singlet oxygen: there is indeed something new under the sun
Peter R. Ogilby
CHEMICAL SOCIETY REVIEWS (2010)
Immunogenic Tumor Cell Death for Optimal Anticancer Therapy: The Calreticulin Exposure Pathway
Laurence Zitvogel et al.
CLINICAL CANCER RESEARCH (2010)
Fresh from the biologic pipeline-2009
Cormac Sheridan
NATURE BIOTECHNOLOGY (2010)
Immunogenic cell death modalities and their impact on cancer treatment
Oliver Kepp et al.
APOPTOSIS (2009)
Chemotherapy induces ATP release from tumor cells
Isabelle Martins et al.
CELL CYCLE (2009)
Enhanced Systemic Immune Reactivity to a Basal Cell Carcinoma Associated Antigen Following Photodynamic Therapy
Edith Kabingu et al.
CLINICAL CANCER RESEARCH (2009)
Mechanism of Drug Sensitivity and Resistance in Melanoma
Caterina A. M. La Porta
CURRENT CANCER DRUG TARGETS (2009)
Chemokine Receptors as Targets for Cancer Therapy
Xuesong Wu et al.
CURRENT PHARMACEUTICAL DESIGN (2009)
Photodynamic therapy (PDT): A short review on cellular mechanisms and cancer research applications for PDT
C. A. Robertson et al.
JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY B-BIOLOGY (2009)
The Vascular Disrupting Agent 5,6-Dimethylxanthenone-4-Acetic Acid Improves the Antitumor Efficacy and Shortens Treatment Time Associated with Photochlor-sensitized Photodynamic Therapy In Vivo
Mukund Seshadri et al.
PHOTOCHEMISTRY AND PHOTOBIOLOGY (2009)
C-type lectins on dendritic cells: key modulators for the induction of immune responses
Yvette van Kooyk
BIOCHEMICAL SOCIETY TRANSACTIONS (2008)
Cancer statistics, 2008
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2008)
Clinical and immunologic results of a phase II trial of sequential imiquimod and photodynamic therapy for vulval intraepithelial neoplasia
Ursula Winters et al.
CLINICAL CANCER RESEARCH (2008)
Pan-Vertebrate Toll-Like Receptors During Evolution
Hiroyuki Oshiumi et al.
CURRENT GENOMICS (2008)
Lost in translation: Problems and pitfalls in translating laboratory observations to clinical utility
Richard Simon
EUROPEAN JOURNAL OF CANCER (2008)
Complement activation cascade and its regulation: Relevance for the response of solid tumors to photodynamic therapy
Mladen Korbelik et al.
JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY B-BIOLOGY (2008)
Mincle is an ITAM-coupled activating receptor that senses damaged cells
Sho Yamasaki et al.
NATURE IMMUNOLOGY (2008)
Photodynamic therapy plus low-dose cyclophosphamide generates antitumor immunity in a mouse model
Ana P. Castano et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Acute phase response induction by cancer treatment with photodynamic therapy
Mladen Korbelik et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Molecular characteristics of immunogenic cancer cell death
A. Tesniere et al.
CELL DEATH AND DIFFERENTIATION (2008)
Photodynamic therapy enhancement of antitumor immunity is regulated by Neutrophils
Phiaretos C. Kousis et al.
CANCER RESEARCH (2007)
The death of human cancer cells following photodynamic therapy: Apoptosis competence is necessary for Bcl-2 protection but not for induction of autophagy
Liang-Yan Xue et al.
PHOTOCHEMISTRY AND PHOTOBIOLOGY (2007)
Towards a better way to die with chemotherapy - Role of heat shock protein exposure on dying tumor cells
Radek Spisek et al.
CELL CYCLE (2007)
CD8+ T cell-mediated control of distant tumours following local photodynamic therapy is independent of CD4+ T cells and dependent on natural killer cells
E. Kabingu et al.
BRITISH JOURNAL OF CANCER (2007)
Initiation of apoptosis and autophagy by the Bcl-2 antagonist HA14-1
David Kessel et al.
CANCER LETTERS (2007)
Activation of complement C3, C5, and C9 genes in tumors treated by photodynamic therapy
Brandon Stott et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2007)
Potentiation of photodynamic therapy of cancer by complement:: the effect of γ-inulin
M. Korbelik et al.
BRITISH JOURNAL OF CANCER (2007)
DAMPs, PAMPs and alarmins: all we need to know about danger
Marco E. Bianchi
JOURNAL OF LEUKOCYTE BIOLOGY (2007)
RAGE: A single receptor for several ligands and different cellular responses: The case of certain S100 proteins
Rosario Donato
CURRENT MOLECULAR MEDICINE (2007)
The natural history of cervical HPV infection: unresolved issues
Ciaran B. J. Woodman et al.
NATURE REVIEWS CANCER (2007)
Evidence for a bystander role of neutrophils in the response to systemic 5-aminolevulinic acid-based photodynamic therapy
Henriette S. de Bruijn et al.
PHOTODERMATOLOGY PHOTOIMMUNOLOGY & PHOTOMEDICINE (2006)
Photodynamic therapy-generated vaccine for cancer therapy
M Korbelik et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2006)
Acute phase response-associated systemic neutrophil mobilization in mice bearing tumors treated by photodynamic therapy
Ivana Cecic et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2006)
Adverse effects of the humanized antibodies used as cancer therapeutics
Jean Klastersky
CURRENT OPINION IN ONCOLOGY (2006)
Photodynamic therapy and anti-tumour immunity
Ana P. Castano et al.
NATURE REVIEWS CANCER (2006)
PDT-associated host response and its role in the therapy outcome
Mladen Korbelik
LASERS IN SURGERY AND MEDICINE (2006)
Regulatory T cells, tumour immunity and immunotherapy
WP Zou
NATURE REVIEWS IMMUNOLOGY (2006)
Regulatory T cells in immune surveillance and treatment of cancer
T Yamaguchi et al.
SEMINARS IN CANCER BIOLOGY (2006)
In vivo sites and cellular mechanisms of T reg cell-mediated suppression
AY Rudensky et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
Imbalance of regulatory T cells in human autoimmune diseases
C Dejaco et al.
IMMUNOLOGY (2006)
Role of complement anaphylatoxin C3a in photodynamic therapy-elicited engagement of host neutrophils and other immune cells
I Cecic et al.
PHOTOCHEMISTRY AND PHOTOBIOLOGY (2006)
A green fluorescent protein-expressing murine tumour but not its wild-type counterpart is cured by photodynamic therapy
AP Castano et al.
BRITISH JOURNAL OF CANCER (2006)
How do CD4+CD25+ regulatory T cells control autoimmunity?
JA Bluestone et al.
CURRENT OPINION IN IMMUNOLOGY (2005)
Immune responses to p53 in patients with cancer:enrichment in tetramer+p53 peptide-specific T cells and regulatory T cells at tumor sites
AE Albers et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2005)
Tumor cells convert immature myeloid dendritic cells into TGF-β-secreting cells inducing CD4+CD25+ regulatory T cell proliferation
F Ghiringhelli et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Immunostimulatory effects of low-dose cyclophosphamide are controlled by inducible nitric oxide synthase
M Loeffler et al.
CANCER RESEARCH (2005)
TGF-β1 maintains suppressor function and Foxp3 expression in CD4+CD25+ regulatory T cells
JC Marie et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
A well adapted regulatory contrivance: regulatory T cell development and the forkhead family transcription factor Foxp3
JD Fontenot et al.
NATURE IMMUNOLOGY (2005)
CD4+CD25+ T regulatory cells, immunotherapy of cancer, and interleukin-2
PA Antony et al.
JOURNAL OF IMMUNOTHERAPY (2005)
Enhancement of laser cancer treatment by a chitosan-derived immunoadjuvant
WR Chen et al.
PHOTOCHEMISTRY AND PHOTOBIOLOGY (2005)
Choice of oxygen-conserving treatment regimen determines the inflammatory response and outcome of photodynamic therapy of tumors
BW Henderson et al.
CANCER RESEARCH (2004)
CD4+CD25+ regulatory T cells suppress tumor immunity but are sensitive to cyclophosphamide which allows immunotherapy of established tumors to be curative
F Ghiringhelli et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2004)
Current clinical and preclinical photosensitizers for use in photodynamic therapy
MR Detty et al.
JOURNAL OF MEDICINAL CHEMISTRY (2004)
Downregulation of ICAM-1 and VCAM-1 expression in endothelial cells treated by photodynamic therapy
C Volanti et al.
ONCOGENE (2004)
Distinct robes of CTLA-4 and TGF-β in CD4+CD25+ regulatory T cell function
QZ Tang et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2004)
Overlap between molecular markers expressed by naturally occurring CD4+CD25+ regulatory T cells and antigen specific CD4+CD25+ and CD8+CD28- T suppressor cells
L Scotto et al.
HUMAN IMMUNOLOGY (2004)
Adjuvant treatment for complement activation increases the effectiveness of photodynamic therapy of solid tumors
M Korbelik et al.
PHOTOCHEMICAL & PHOTOBIOLOGICAL SCIENCES (2004)
Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-β induction of transcription factor Foxp3
WJ Chen et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Molecular identification of a danger signal that alerts the immune system to dying cells
Y Shi et al.
NATURE (2003)
Role of cytokines in photodynamic therapy-induced local and systemic inflammation
SO Gollnick et al.
BRITISH JOURNAL OF CANCER (2003)
Apoptotic, but not necrotic, tumor cell vaccines induce a potent immune response in vivo
SR Scheffer et al.
INTERNATIONAL JOURNAL OF CANCER (2003)
Mediators of peripheral blood neutrophilia induced by photodynamic therapy of solid tumors
I Cecic et al.
CANCER LETTERS (2002)
Neutrophils as in inflammatory and immune effectors in photodynamic therapy-treated mouse SCCVII tumours
JH Sun et al.
PHOTOCHEMICAL & PHOTOBIOLOGICAL SCIENCES (2002)
The role of apoptosis in response to photodynamic therapy: what, where, why, and how
NL Oleinick et al.
PHOTOCHEMICAL & PHOTOBIOLOGICAL SCIENCES (2002)
State of the art in the delivery of photosensitizers for photodynamic therapy
YN Konan et al.
JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY B-BIOLOGY (2002)
Photosensitized oxidation of membrane lipids: reaction pathways, cytotoxic effects, and cytoprotective mechanisms
AW Girotti
JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY B-BIOLOGY (2001)
Enhancement of the photodynamic antitumor effect by streptococcal preparation OK-432 in the mouse carcinoma
M Uehara et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2000)
The immune system - First of two parts
PJ Delves et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Share Paper
